Target intelligence / Profile preview

Ribosomal protein L19 pseudogene 21 (RPL19P21)

Target: RPL19P21
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L19 pseudogene 21 (RPL19P21) is a processed pseudogene in the human genome that shares sequence similarity with the gene encoding ribosomal protein L19 but does not code for a functional protein. Like other processed pseudogenes of ribosomal protein genes, RPL19P21 is a non-coding remnant and is typically not transcribed or translated. Such pseudogenes are distributed throughout the human genome and result from retrotransposition events; they do not possess a biological function or role in disease and are not therapeutic targets[2][4][11][15].

Other names: RPL19_13_1819RPL19P21

Beyond the preview

Go deeper on Ribosomal protein L19 pseudogene 21 (RPL19P21).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L19 pseudogene 21 (RPL19P21).

Explore the full profile